Clinical trial
A First In Human Study of the MCL-1 Inhibitor, ABBV-467
NCT04178902 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A First In Human Study of the MCL-1 Inhibitor, ABBV-467
- Lead sponsor
- AbbVie
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- May 19, 2020
- Completion date
- April 16, 2021
- Enrollment
- 8 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.
cancer, multiple myeloma (mm)